Hyperfine promotes Tom Teisseyre to COO; CMO/CSO Siddiqui moves to part-time

Hyperfine, Inc.

Tom Teisseyre (formerly CPO) appointed COO effective July 24, 2023; base salary $425K, target bonus 50%, option grant of 200K shares.
Khan Siddiqui transitions to 20% part-time CMO/CSO; salary reduced to $87,360/year; removed from Severance Plan.
Severance Plan amended to remove Siddiqui; remaining participants include CEO, CFO, and Teisseyre.
Teisseyre will oversee product design, clinical science, operations, cybersecurity, and technical service.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Khan Siddiqui

Chief Medical Officer and Chief Strategy Officer

HYPR · Hyperfine, Inc.

Effective: 2023-07-24
Filed: July 18, 2023, 7:59 PM ET

the Company entered into a schedule and salary modification letter agreement (the “Modification Agreement”) with Khan Siddiqui, M.D., the Company’s Chief Medical Officer and Chief Strategy Officer, effective July 24, 2023.

Role change

Thomas Teisseyre

Chief Operating Officer

HYPR · Hyperfine, Inc.

Effective: 2023-07-24
Filed: July 18, 2023, 7:59 PM ET

Thomas Teisseyre, Ph.D., the Company’s Chief Product Officer, has been appointed by the Board of Directors of the Company (the “Board”) to serve as Chief Operating Officer of the Company, effective as of July 24, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Khan Siddiqui changed role as Chief Medical Officer and Chief Strategy Officer at Hyperfine, Inc..

Action: modified
Role: Chief Medical Officer and Chief Strategy Officer

Exact text from the filing

the Company entered into a schedule and salary modification letter agreement (the “Modification Agreement”) with Khan Siddiqui, M.D., the Company’s Chief Medical Officer and Chief Strategy Officer, effective July 24, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Teisseyre was appointed as Chief Operating Officer at Hyperfine, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

Thomas Teisseyre, Ph.D., the Company’s Chief Product Officer, has been appointed by the Board of Directors of the Company (the “Board”) to serve as Chief Operating Officer of the Company, effective as of July 24, 2023

View on SEC.gov

Hyperfine, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-033349

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.